# Praecitrullus fistulosus Extract Exhibits Antidiabetic Potential by Augmenting Insulin-Signaling Cascade, GLUT-4 and IRS-1, in Streptozotocin–Nicotinamide-Induced Diabetic Rats

**Authors:** Ayesha Amjad, Azmat Ullah Khan, Qaisar Raza, Sajid Khan Tahir

PMC · DOI: 10.3390/foods14213764 · 2025-11-03

## TL;DR

A plant extract from Praecitrullus fistulosus may help treat diabetes by improving insulin signaling and reducing oxidative stress in diabetic rats.

## Contribution

The study demonstrates the antidiabetic potential of Praecitrullus fistulosus extract via modulation of insulin signaling pathways in diabetic rats.

## Key findings

- P. fistulosus extract improved glucose tolerance and insulin levels in diabetic rats.
- The extract upregulated genes and proteins involved in the insulin-signaling cascade.
- It reduced oxidative stress and lipid profile in a dose-dependent manner.

## Abstract

Diabetes mellitus is largely driven by oxidative stress that disrupts insulin signaling, leading to failure in insulin-mediated glucose absorption. Exploration of natural bioactive compounds is fueled by their promising role in correcting redox imbalance. This study aims to investigate the antidiabetic effect of the methanolic extract of Praecitrullus fistulosus, potentially by transcriptional modulation in streptozotocin–nicotinamide-induced diabetic rats. Male Wistar albino rats (n = 36) were assigned to six groups: normal control; diabetic control; standard drug group; and three treatment groups receiving P. fistulosus extract orally at doses of 200, 400, and 600 mg/kg body weight, respectively, for 30 consecutive days. Diabetes was induced in all groups, except for normal control, by intraperitoneal co-administration of streptozotocin and nicotinamide. Nicotinamide (100 mg/kg) was injected 15 min prior to a single dose of streptozotocin (50 mg/kg). Baseline and endpoint assessments of weight and blood glucose levels were performed. Blood was processed to assess insulin-related indices, lipid profile, and oxidative stress markers. q-PCR and Western blotting were utilized to explore the underlying molecular mechanisms. The diabetic control-group rats exhibited impaired glucose tolerance due to the marked reduction in serum insulin levels, compromised β-cell function, and substantial rise in lipid profile and oxidative stress parameters. Oral administration of P. fistulosus methanolic extract effectively mitigated these alterations in a dose-dependent manner, accompanied by the upregulation of both gene and protein expression involved in the insulin-signaling cascade.

## Linked entities

- **Genes:** SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517], IRS1 (insulin receptor substrate 1) [NCBI Gene 3667]
- **Chemicals:** streptozotocin (PubChem CID 29327), nicotinamide (PubChem CID 936)
- **Diseases:** diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Genes:** Irs1 (insulin receptor substrate 1) [NCBI Gene 25467] {aka IRS1IRM}, Slc2a4 (solute carrier family 2 member 4) [NCBI Gene 25139] {aka Glut4}
- **Diseases:** Diabetes (MESH:D003920), impaired glucose tolerance (MESH:D018149)
- **Chemicals:** blood glucose (MESH:D001786), P. fistulosus extract (-), glucose (MESH:D005947), lipid (MESH:D008055), Nicotinamide (MESH:D009536), Streptozotocin (MESH:D013311)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Benincasa fistulosa (Indian baby pumpkin, species) [taxon 252558]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12609042/full.md

---
Source: https://tomesphere.com/paper/PMC12609042